Disopyramide Sustained-Release Capsules and Metadate ER
Determining the interaction of Disopyramide Sustained-Release Capsules and Metadate ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Metadate CD, Ritalin SR, Daytrana, Methylin ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Disopyramide Sustained-Release Capsules-Metaderm Mild
- Disopyramide Sustained-Release Capsules-Metaderm Regular
- Disopyramide Sustained-Release Capsules-Metafolbic
- Disopyramide Sustained-Release Capsules-Metafolbic Plus
- Disopyramide Sustained-Release Capsules-Metafolbic Plus RF
- Disopyramide Sustained-Release Capsules-Metaglip
- Metadate ER-DisperMox
- Metadate ER-Disposable Enema rectal
- Metadate ER-Disulfiram
- Metadate ER-Dithol Solution
- Metadate ER-Ditropan
- Metadate ER-Ditropan XL